Description
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.
Reviews
There are no reviews yet.